30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Aradigm Corp (ARDMQ)

Track

Stock chart
Ticker: ARDMQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Froehlich Juergen Kurt
Chief Medical Officer
1 sale — total 367 USD
Sale 19 Sep 2018
Value US$4,557,752.51 | Price 283.02 | Shares 38,252
Sale 29 Jan 2018
Value US$505,084.35 | Price 210.22 | Shares 73,873
Planned sale 4 Apr 2017
Value US$5,685.15 | Price 1.51 | Shares 3,765
Planned sale 4 Oct 2016
Value US$2,859.48 | Price 6.76 | Shares 423
Planned sale 21 Jun 2016
Value US$1,481.85 | Price 4.45 | Shares 333
Sale 13 Dec 2013
Value US$567.80 | Price 0.17 | Shares 3,340
Buy 27 Aug 2013
Value US$4,999,999.92 | Price 0.12 | Shares 40,322,580
Buy 11 Dec 2012
Value US$5,000,000.04 | Price 0.12 | Shares 41,666,667
Buy 7 Jul 2011
Value US$2,018,750.00 | Price 0.19 | Shares 10,625,000
Sale 5 Nov 2010
Value US$68,691.35 | Price 0.17 | Shares 401,469
Sale 4 Nov 2010
Value US$38,182.50 | Price 0.17 | Shares 225,000
Sale 3 Nov 2010
Value US$40,750.00 | Price 0.16 | Shares 250,000
Sale 2 Nov 2010
Value US$42,248.70 | Price 0.16 | Shares 256,675
Sale 1 Nov 2010
Value US$39,030.63 | Price 0.17 | Shares 236,406
Buy 18 Jun 2010
Value US$2,300,915.51 | Price 0.12 | Shares 19,433,408
Sale 29 Oct 2008
Value US$1,400,000.00 | Price 0.25 | Shares 5,600,000
Buy 21 Oct 2008
Value US$2,400.00 | Price 0.24 | Shares 10,000
Buy 20 Oct 2008
Value US$4,080.00 | Price 0.24 | Shares 17,000
Buy 13 Oct 2008
Value US$6,000.00 | Price 0.24 | Shares 25,000
Buy 10 Oct 2008
Value US$10,602.00 | Price 0.24 | Shares 45,000
Sale 6 Oct 2008
Value US$350,000.00 | Price 0.35 | Shares 1,000,000
Buy 5 Jun 2008
Value US$11,250.00 | Price 0.75 | Shares 15,000
Buy 4 Apr 2008
Value US$5,250.00 | Price 1.05 | Shares 5,000
Buy 3 Apr 2008
Value US$15,750.00 | Price 1.05 | Shares 15,000
Buy 2 Apr 2008
Value US$20,900.00 | Price 1.05 | Shares 20,000
Buy 15 Jan 2008
Value US$28,347.50 | Price 1.45 | Shares 19,550
Buy 15 Jan 2008
Value US$705.00 | Price 1.41 | Shares 500
Buy 15 Jan 2008
Value US$21,182.00 | Price 1.40 | Shares 15,130
Buy 15 Jan 2008
Value US$695.00 | Price 1.39 | Shares 500
Buy 15 Jan 2008
Value US$15,180.00 | Price 1.38 | Shares 11,000
Buy 15 Jan 2008
Value US$4,352.00 | Price 1.36 | Shares 3,200
Buy 15 Jan 2008
Value US$85,212.00 | Price 1.35 | Shares 63,120
Buy 15 Jan 2008
Value US$21,440.00 | Price 1.34 | Shares 16,000
Buy 15 Jan 2008
Value US$55,328.00 | Price 1.33 | Shares 41,600
Buy 15 Jan 2008
Value US$9,900.00 | Price 1.32 | Shares 7,500
Buy 15 Jan 2008
Value US$4,585.00 | Price 1.31 | Shares 3,500
Buy 15 Jan 2008
Value US$3,870.00 | Price 1.29 | Shares 3,000
Buy 15 Jan 2008
Value US$8,960.00 | Price 1.28 | Shares 7,000
Buy 1 Nov 2007
Value US$889,000.00 | Price 1.40 | Shares 635,000
Buy 13 Sep 2007
Value US$152,904.00 | Price 1.38 | Shares 110,800
Buy 11 Sep 2007
Value US$420,000.00 | Price 1.40 | Shares 300,000
Buy 1 Mar 2007
Value US$124,614.00 | Price 1.40 | Shares 89,010
Buy 25 Jan 2007
Value US$4,750.00 | Price 0.95 | Shares 5,000
Buy 25 Jan 2007
Value US$19,000.00 | Price 0.95 | Shares 20,000
Sale 4 Mar 2004
Value US$7,970.11 | Price 2.71 | Shares 2,941
Sale 20 Feb 2004
Value US$24,090.70 | Price 2.35 | Shares 10,247
Sale 20 Feb 2004
Value US$24,090.70 | Price 2.35 | Shares 10,247
Sale 20 Feb 2004
Value US$24,090.70 | Price 2.35 | Shares 10,247
Sale 20 Feb 2004
Value US$24,090.70 | Price 2.35 | Shares 10,247
Sale 20 Feb 2004
Value US$24,090.70 | Price 2.35 | Shares 10,247
Sale 20 Feb 2004
Value US$24,090.70 | Price 2.35 | Shares 10,247
Sale 20 Feb 2004
Value US$24,090.70 | Price 2.35 | Shares 10,247
Sale 20 Feb 2004
Value US$24,090.70 | Price 2.35 | Shares 10,247
Sale 20 Feb 2004
Value US$24,090.70 | Price 2.35 | Shares 10,247
Sale 20 Feb 2004
Value US$24,090.70 | Price 2.35 | Shares 10,247
Sale 7 Jan 2004
Value US$226.72 | Price 2.08 | Shares 109
Sale 7 Jan 2004
Value US$226.72 | Price 2.08 | Shares 109
Sale 7 Jan 2004
Value US$453.44 | Price 2.08 | Shares 218
Sale 7 Jan 2004
Value US$906.88 | Price 2.08 | Shares 436
Sale 7 Jan 2004
Value US$4,200.00 | Price 2.10 | Shares 2,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-09-20 2018-09-19 S Sale Froehlich Juergen Kurt

Chief Medical Officer

Officer
38,252 -38.9%
283.02
US$4,557,753 		38,252 -38.9% 283.02 US$4,557,753
2018-01-31 2018-01-29 S Sale Froehlich Juergen Kurt

Chief Medical Officer

Officer
73,873 -9.9%
210.22
US$505,084 		73,873 -9.9% 210.22 US$505,084
2017-04-06 2017-04-04 PlS Planned sale Froehlich Juergen Kurt

Chief Medical Officer
55,443 +7.1%
56.92
US$2,468,225 		55,443 +7.1% 56.92 US$2,468,225
2016-10-05 2016-10-04 PlS Planned sale Froehlich Juergen Kurt

Chief Medical Officer

Officer
423 -0.5%
6.76
US$2,859 		423 -0.5% 6.76 US$2,859
2016-06-23 2016-06-21 PlS Planned sale Froehlich Juergen Kurt

Chief Medical Officer

Officer
333 -0.4%
4.45
US$1,482 		333 -0.4% 4.45 US$1,482
2013-12-16 2013-12-13 S Sale THOMPSON VIRGIL Non-Executive Director
3,340 -0.3%
0.17
US$568 		3,340 -0.3% 0.17 US$568
2013-08-29 2013-08-27 B Purchase First Eagle Investment Management, LLC Large shareholder
40,322,580
0.12
US$5,000,000 		40,322,580 0.12 US$5,000,000
2012-12-13 2012-12-11 B Purchase First Eagle Investment Management, LLC Large shareholder
41,666,667 +57.6%
0.12
US$5,000,000 		41,666,667 +57.6% 0.12 US$5,000,000
2011-07-11 2011-07-07 B Purchase First Eagle Value in Biotechnology Master Fund, Ltd.

See Footnote below

Large shareholder
10,625,000 +17.5%
0.19
US$2,018,750 		10,625,000 +17.5% 0.19 US$2,018,750
2010-11-09 2010-11-05 S Sale NOVO NORDISK A S Large shareholder
401,469 -1.5%
0.17
US$68,691 		401,469 -1.5% 0.17 US$68,691
2010-11-05 2010-11-04 S Sale NOVO NORDISK A S Large shareholder
225,000 -0.8%
0.17
US$38,182 		225,000 -0.8% 0.17 US$38,182
2010-11-04 2010-11-03 S Sale NOVO NORDISK A S Large shareholder
250,000 -0.9%
0.16
US$40,750 		250,000 -0.9% 0.16 US$40,750
2010-11-03 2010-11-02 S Sale NOVO NORDISK A S Large shareholder
256,675 -0.9%
0.16
US$42,249 		256,675 -0.9% 0.16 US$42,249
2010-11-02 2010-11-01 S Sale NOVO NORDISK A S Large shareholder
236,406 -0.9%
0.17
US$39,031 		236,406 -0.9% 0.17 US$39,031
2010-06-22 2010-06-18 B Purchase First Eagle Value in Biotechnology Master Fund, Ltd.

See Remarks.

Large shareholder
19,433,408 +52.4%
0.12
US$2,300,916 		19,433,408 +52.4% 0.12 US$2,300,916
2008-10-31 2008-10-29 S Sale RA CAPITAL MANAGEMENT, LLC Large shareholder
5,600,000 -83.8%
0.25
US$1,400,000 		5,600,000 -83.8% 0.25 US$1,400,000
2008-10-23 2008-10-21 B Purchase TANG KEVIN C Large shareholder
10,000 +0.2%
0.24
US$2,400 		10,000 +0.2% 0.24 US$2,400
2008-10-22 2008-10-20 B Purchase TANG KEVIN C Large shareholder
17,000 +0.3%
0.24
US$4,080 		17,000 +0.3% 0.24 US$4,080
2008-10-15 2008-10-13 B Purchase TANG KEVIN C Large shareholder
25,000 +0.5%
0.24
US$6,000 		25,000 +0.5% 0.24 US$6,000
2008-10-14 2008-10-10 B Purchase TANG KEVIN C Large shareholder
45,000 +0.8%
0.24
US$10,602 		45,000 +0.8% 0.24 US$10,602
2008-10-08 2008-10-06 S Sale RA CAPITAL MANAGEMENT, LLC Large shareholder
1,000,000 -13.0%
0.35
US$350,000 		1,000,000 -13.0% 0.35 US$350,000
2008-06-06 2008-06-05 B Purchase GONDA IGOR

Chief Executive Officer

Executive Director
15,000 +30.6%
0.75
US$11,250 		15,000 +30.6% 0.75 US$11,250
2008-04-10 2008-04-04 B Purchase BARKER FRANK H Non-Executive Director
5,000 +14.3%
1.05
US$5,250 		5,000 +14.3% 1.05 US$5,250
2008-04-10 2008-04-03 B Purchase BARKER FRANK H Non-Executive Director
15,000 +75.0%
1.05
US$15,750 		15,000 +75.0% 1.05 US$15,750
2008-04-10 2008-04-02 B Purchase BARKER FRANK H Non-Executive Director
20,000 +inf%
1.05
US$20,900 		20,000 +inf% 1.05 US$20,900
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
19,550 +0.3%
1.45
US$28,348 		19,550 +0.3% 1.45 US$28,348
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
500 +0.0%
1.41
US$705 		500 +0.0% 1.41 US$705
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
15,130 +0.2%
1.40
US$21,182 		15,130 +0.2% 1.40 US$21,182
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
500 +0.0%
1.39
US$695 		500 +0.0% 1.39 US$695
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
11,000 +0.1%
1.38
US$15,180 		11,000 +0.1% 1.38 US$15,180
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
3,200 +0.0%
1.36
US$4,352 		3,200 +0.0% 1.36 US$4,352
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
63,120 +0.8%
1.35
US$85,212 		63,120 +0.8% 1.35 US$85,212
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
16,000 +0.2%
1.34
US$21,440 		16,000 +0.2% 1.34 US$21,440
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
41,600 +0.6%
1.33
US$55,328 		41,600 +0.6% 1.33 US$55,328
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
7,500 +0.1%
1.32
US$9,900 		7,500 +0.1% 1.32 US$9,900
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
3,500 +0.0%
1.31
US$4,585 		3,500 +0.0% 1.31 US$4,585
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
3,000 +0.0%
1.29
US$3,870 		3,000 +0.0% 1.29 US$3,870
2008-01-16 2008-01-15 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
7,000 +0.1%
1.28
US$8,960 		7,000 +0.1% 1.28 US$8,960
2007-11-05 2007-11-01 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
635,000 +9.3%
1.40
US$889,000 		635,000 +9.3% 1.40 US$889,000
2007-09-13 2007-09-13 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
110,800 +1.6%
1.38
US$152,904 		110,800 +1.6% 1.38 US$152,904
2007-09-13 2007-09-11 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
300,000 +4.7%
1.40
US$420,000 		300,000 +4.7% 1.40 US$420,000
2007-03-28 2007-03-01 B Purchase RA CAPITAL MANAGEMENT, LLC Large shareholder
89,010 +1.4%
1.40
US$124,614 		89,010 +1.4% 1.40 US$124,614
2007-01-30 2007-01-25 B Purchase OTULANA BABTUNDE A

VP of Clincal Affairs

Officer
5,000 +165.6%
0.95
US$4,750 		5,000 +165.6% 0.95 US$4,750
2007-01-30 2007-01-25 B Purchase GONDA IGOR

Chief Executive Officer

Executive Director
20,000 +67.5%
0.95
US$19,000 		20,000 +67.5% 0.95 US$19,000
2004-03-08 2004-03-04 S Sale PERRY MARK W Large shareholder
2,941 -100.0%
2.71
US$7,970 		2,941 -100.0% 2.71 US$7,970
2004-02-24 2004-02-20 S Sale NEWHALL CHARLES W III Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale KRAMLICH C RICHARD Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale PERRY MARK W Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale NEHRA JOHN M
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale DORMAN NANCY L Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale MCCONNELL THOMAS C Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale BARRIS PETER J Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale KASE RONALD H
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale ALSOP STEWART II Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-24 2004-02-20 S Sale MORRIS PETER Large shareholder
10,247 -100.0%
2.35
US$24,091 		10,247 -100.0% 2.35 US$24,091
2004-02-03 2004-01-07 S Sale TRAINOR III EUGENE A Large shareholder
109 -100.0%
2.08
US$227 		109 -100.0% 2.08 US$227
2004-02-03 2004-01-07 S Sale TRAINOR III EUGENE A Large shareholder
109 -100.0%
2.08
US$227 		109 -100.0% 2.08 US$227
2004-02-03 2004-01-07 S Sale TRAINOR III EUGENE A Large shareholder
218 -100.0%
2.08
US$453 		218 -100.0% 2.08 US$453
2004-02-03 2004-01-07 S Sale TRAINOR III EUGENE A Large shareholder
436 -100.0%
2.08
US$907 		436 -100.0% 2.08 US$907
2004-01-09 2004-01-07 S Sale PERRY MARK W Large shareholder
2,000 -40.5%
2.10
US$4,200 		2,000 -40.5% 2.10 US$4,200
Explore more

More insider trading research around Aradigm Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America